Insider trades
Samuel Whiting, Chief Officer of Tempest Therapeutics TPST, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/01/02.
Samuel Whiting
Chief Medical Officer
- Company
- Tempest Therapeutics TPST
- First filing
- 23/01/05
- Trades
- 5 trades
- Buys / sales
- 1 / 0
- 12-month net buying
- No record
- Last trade
- 25/01/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 24/07/02 | 24/07/03 | 4,672 sh | $2.13 | $9,951.36 | +95.3% |